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Objective. Many performance measurement systems are designed to identify differ-
ences in the quality provided by health plans or facilities. However, we know little about
whether different methods of performance measurement provide similar answers about
the quality of care of health care organizations. To examine this question, we used three
different measurement approaches to assess quality of care delivered in veteran affairs
(VA) facilities.
Data Sources/Study Setting. Medical records for 621 patients at 26 facilities in two
VA regions.
Study Design. We examined agreements in quality conclusions using: focused ex-
plicit (38 measures for six conditions/prevention), global explicit (372 measures for 26
conditions/prevention), and structured implicit review physician-rated care (a single
global rating of care for three chronic conditions and overall acute, chronic and pre-
ventive care). Trained nurse abstractors and physicians reviewed all medical records.
Correlations between scores from the three systems were adjusted for measurement
error in each using multilevel regression models.
Results. Intercorrelations of scores were generally moderate to high across all three
systems, and rose with adjustment for measurement error. Site-level correlations for
prevention and diabetes care were particularly high. For example, adjusted for mea-
surement error at the site level, prevention quality was correlated at 0.89 between the
implicit and global systems, 0.67 between implicit and focused, and 0.73 between global
and focused systems.
Conclusions. We found moderate to high agreement in quality scores across the three
profiling systems for most clinical areas, indicating that all three were measuring
a similar construct called ‘‘quality.’’ Adjusting for measurement error substantially
enhanced our ability to identify this underlying construct.
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Although the number of performance measures that are used to monitor and
compare the quality of health care organizations continues to proliferate, we
know little about the extent to which results from the many current methods to
measure quality agree with one another. With the costs associated with quality
monitoring increasing, and pay-for-performance initiatives becoming more
broadly promoted, healthcare organizations and providers are rightly asking
how much of their performance profiles depends on the choice of quality
measures or profiling systems used. As important is the broader question of
whether these different quality measures are tapping into a unified construct
representing quality of care. Fundamentally, the strategy of contracting with or
seeking care from certain providers or organizations based on quality requires
a coherent and measurable construct that represents the quality of care. Yet,
most current profiles of care quality are based on a limited set of feasible
measures that may or may not represent the broader construct of health care
quality.
For over three decades, experts have argued whether it is possible to
capture such a health care quality ‘‘construct’’ by using measures that
assess the quality of technical care. Donabedian (1985) asserted that methods
that measure care quality can generally be categorized into two approaches:
those involving implicit expert (physician) judgments of individual cases (im-
plicit review) and those involving explicit objective standards (referred to as
explicit review, although the measures are themselves developed by expert
judgments about the literature). A number of studies have attempted to val-
idate quality constructs by examining whether the process of care for discrete
conditions as judged by explicit review agreed with implicit judgments of
the same care. As long ago as the 1970s, Brook examined agreements in pro-
cess quality using implicit and explicit review systems for three conditions.
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He found that, while all explicit criteria were infrequently met for any con-
dition, care was rarely judged as adequate by physicians when 50 percent or
fewer of explicit criteria were met (Brook and Appel 1973; Donabedian 1985).
Subsequently a number of studies have found both evidence of agreement
between explicit and implicit measures (Greenfield et al. 1978; Hulka et al.
1979; Rubenstein et al. 1990; Ashton et al. 1999) as well as lack of agreement
(Weingart et al. 2002).
However, these studies never compared more than two independent
measurement systems and in assessing the level of agreement did not account
for the imprecision that often plagues measurement of quality, as it also does
many other areas of clinical science. Further, the implicit reviews in the above
studies were often conducted by the same physicians who developed the
explicit standards used in the explicit reviews, thus diminishing the indepen-
dence of the two measurement systems (Brook and Appel 1973; Hulka et al.
1979). The studies were also conducted largely in hospitalized patients with
a limited set of conditions——none examined care longitudinally or across
the continuum of inpatient care and outpatient care (Greenfield et al. 1978;
Rubenstein et al. 1990).
Furthermore, explicit measurement systems have improved substan-
tially over the intervening years so there are now two major types. The first
type, focused explicit review systems, rely upon explicit assessments of quality
for a limited set of supported and feasible measures to evaluate care (National
Committee for Quality Assurance [NCQA] 2005). Examples of focused sys-
tems include the Health Plan Employer Data and Information Set (HEDIS)
(NCQA 2005) and the Department of Veterans Affairs’ (VA) chart-review
based performance measurement system, the External Peer Review Program
(EPRP) (Kizer et al. 2000; Jha et al. 2003; Perlin, Kolodner, and Roswell 2004).
While limited in scope, focused systems have the advantages of being
concrete, easily understood and generally actionable at the level of the indi-
vidual measure. Second, at the other end of the spectrum are more global
explicit approaches for quality assessment, such as RAND’s QA Tools system
(McGlynn et al. 2003; Kerr et al. 2004). Global measurement systems use a
broader set of quality measures for a much larger number of conditions, and
results are reported as summary scores (e.g., for chronic disease or preventive
care), thereby making them less effective at informing quality improvement
for any individual measure. However, global systems could potentially spark
broader systematic change, are more difficult to game, and could be partic-
ularly useful for informing contracting decisions and pay-for-performance
initiatives because they appear better to represent overall care.
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The method of implicit review for quality assessment has also been
refined. Structured physician implicit review has been used as a standard tool
on many landmark research studies on the quality of care and on medical
errors (Rubenstein et al. 1990; Brennan et al. 1991; Rubin et al. 1992). While
the main criticism of implicit peer review has been the relatively low inter-
rater reliability (Rubin et al. 1992; Ashton et al. 1999), the method has been
shown to have moderately high reliability in some cases (Rubenstein et al.
1990; Hofer et al. 2004). Further, more recently developed statistical methods
can adjust for these moderate levels of reliability, thus allowing more reliable
profiling using this method (Hofer et al. 2004).
Therefore, as demands intensify that health care organizations increase
the level of performance monitoring and forge ahead into the world of pay-for-
performance, it is critical to ask whether the tools employed to assess quality
are capable of supplying the required information about performance. First, is
there evidence of the validity of a measurable construct representing overall
quality as reflected in agreement between different measurement systems
(explicit global, explicit focused, and implicit) across outpatient and inpatient
settings? Second, does agreement across the measurement systems differ by
discrete medical areas or conditions? Finally, can the assessments of quality be
improved by employing newer statistical methods that provide more precise
quality estimates? Specifically, does accounting for the measurement error in
each of these independent quality measurement systems improve agreement
between the systems? To answer these questions, we evaluated technical pro-
cess quality among 621 patients in 26 VA health care facilities using three
different measurement systems: focused explicit, global explicit, and struc-
tured implicit review.
METHODS
Specific Instrument Selection, Development, and Testing
The three different measurement systems used in this study all evaluated the
processes of medical care rather than the outcomes (Appendix 1). The focused
and global explicit instruments were selected on the basis of their comparable
scope and widespread use in operational or research settings (McGlynn et al.
2003; Perlin, Kolodner, and Roswell 2004). The focused explicit review in-
strument modified from the 2001 version of the VA EPRP instrument, mea-
sured 38 processes of care, and the global explicit review instrument, modified
from RAND QA Tools, measured up to 372 processes of care (Table 1).
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A structured implicit review instrument was developed for this project
(Hofer et al. 2004) based on methods employed in previously published stud-
ies (Rubenstein et al. 1990; Hayward, McMahon, and Bernard 1993; Hay-
ward et al. 1993) (see Appendix 1). The structured implicit review instrument
Table 1: Description of the Three Quality Assessment Systems
Dimension

















7 75 (9) 5 62 (16) 20 69 (0)
Diabetes 7 60 (13) 8 76 (6) 13 71 (3)
Hypertension 5 66 (16) 3 94 (4) 26 97 (0)
Ischemic heart disease 0 —— 5 —— 37 ——
Heart failure 0 —— 3 —— 36 ——
Alcohol 0 —— 0 —— 5 ——
Asthma 0 —— 0 —— 25 ——
Atrial fibrillation 0 —— 0 —— 10 ——
Benign prostatic hypertrophy 0 —— 0 —— 4 ——
Cancer pain/palliation 0 —— 0 —— 3 ——
Cerebrovascular disease 0 —— 0 —— 10 ——
Colorectal cancer 0 —— 0 —— 12 ——
Depression 0 —— 0 —— 14 ——
Dyspepsia/peptic ulcer disease 0 —— 0 —— 8 ——
Hyperlipidemia 0 —— 0 —— 7 ——
Osteoarthritis 0 —— 0 —— 3 ——
Prostate cancer 0 —— 0 —— 6 ——
All chronic (total) 5 63 (16) 24 81 (6) 239 74 (1)
Acute (total) 4 83 (1) NA NA 100 58 (0)
Overall (total) 5 65 (15) 38 73 (9) 372 69 (4)
nSpecific domains of care for structured implicit review included assessment of the initial pre-
sentation of the condition (if it occurred during this period), the assessment and monitoring of the
course of the condition, the treatment of signs or symptoms, exacerbations or complications, and
follow-up and the overall quality for the condition or set of conditions. For prevention, ratings were
provided for screening, immunizations, prevention-related counseling, and overall preventive
care.
wRatings for implicit review were based on a six-point scale (‘‘very good,’’ ‘‘good,’’ ‘‘adequate,’’
‘‘borderline poor,’’ ‘‘poor,’’ and ‘‘very poor’’). In order to present a score for implicit review
comparable to the score calculated for the explicit instruments, we estimated the probability for
each patient or facility of receiving an overall rating of adequate or better.
zFacility mean explicit scores for both the global and explicit systems represent the proportion of
eligible processes of care that were received by each patient, aggregated at the level of the site of
care (N 5 26).
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required trained physician reviewers to identify and rate process quality for
three specific chronic conditions contained in both explicit systems (hyper-
tension, diabetes, and chronic obstructive pulmonary disease [COPD]), other
chronic conditions, acute conditions, preventive care, and overall care. Phy-
sicians were instructed to base their assessments on whether appropriate pro-
cesses of care were delivered; that is, whether the care provided care was likely
to enhance outcomes. Care was rated within domains (e.g., assessment, treat-
ment, follow-up, and overall care) using a six-point scale (‘‘very good,’’
‘‘good,’’ ‘‘adequate,’’ ‘‘borderline poor,’’ ‘‘poor,’’ ‘‘very poor’’).
Inter-Rater Reliability
For the explicit instruments the inter-rater reliability of chart abstraction, as
documented in prior studies and reports, is generally 0.9 or higher (McGlynn
et al. 2003). For the structured implicit reviews our reliabilities were compa-
rable or higher to those obtained in prior studies and ranged from 0.2 to 0.5
(Hofer et al. 2004).
Sampling
We constructed a stratified random sample from 26 sites of care (medical
centers and clinics) in 12 health care systems located within two VA regional
networks, one in the Midwest and one in the West. We sampled 621 patients
(out of 106,576) who had at least two primary care outpatient visits during each
of the two study years (10/1/97 to 9/30/99), over-sampling diabetes and
COPD to obtain a minimum of 175 cases for each condition while minimizing
the design effect.
Abstraction
Two separate teams of four professional nurse reviewers experienced in using
each instrument completed the focused and global explicit reviews, after re-
ceiving project specific training. Implicit reviews were conducted by 12 board-
certified internal medicine physicians. The average time per review was 35
minutes for the focused explicit review, 164 minutes for the global explicit
review, and 101 minutes for the implicit review.
Score Construction
From the abstracted data we constructed an unadjusted score for the explicit
quality measures as the proportion of eligible processes of care that were
received by each patient. These patient-level scores were then aggregated to
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produce an average score at the level of the site of care (an average of patient
averages). We present the scores as proportions ranging from 0 to 100 percent
(Table 1).
We also constructed scores for both the implicit review and the two
explicit review methods that took into account the major sources of measure-
ment error inherent in each instrument. Specifically, we used multilevel or-
dinal and logistic regression models to construct scores at the patient and site
level that were adjusted for measurement error. For the implicit review the
major source of measurement error is between independent reviews of a pa-
tient record, or the inter-rater reliability. We estimated the level of reliability of
the implicit reviews by conducting multiple reviews within a sample of pa-
tients (Hofer et al. 2004). By using these repeated measures at the level of the
independent review (the lowest level in the multilevel model), we were able to
estimate and remove this source of measurement error. In addition, we si-
multaneously adjusted for differences in the overall mean rating for each rater,
thus removing any differences in how strict or lenient particular raters were in
assessing quality.
For the explicit reviews, the major source of measurement error is the
variation between the number of items that comprise the score and the fact
that some patients were eligible for only a small number of indicators. For
example, a score in which one out of two processes is met (1/2 or 50 percent) is
less precisely estimated than a score in which seven out of 14 are met (7/14 or
50 percent). By adjusting for this source of error in the multilevel models, we
produced better estimates of the true underlying score measured by an explicit
instrument (in terms of mean squared error) (Bryk and Raudenbush 1992;
Goldstein 1995; Snijders and Bosker 1999). Again we also adjusted for any
differences in scoring across nurse abstractors. See Appendix 2 for further
details of these analytical methods.
The resultant explicit and implicit quality scores were transformed onto
a probability scale for purposes of presentation. In order to present a ‘‘pass
rate’’ for implicit review comparable to the pass rate calculated for the explicit
instruments, we estimated the probability for each patient or facility of re-
ceiving an overall rating of adequate or better.
Comparison of Scores
For comparison with prior studies that have compared explicit and implicit
review (Rubenstein et al. 1990) we first present a table of the implicit review
ratings (collapsed into four categories), and the mean explicit scores received
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by patients falling into each implicit rating (Table 2). These mean scores are
aggregated across all patients and sites, unadjusted for measurement error, and
compared with implicit review ratings using a traditional analysis of variance.
We next present correlations between the different quality measurement
methods unadjusted and adjusted for measurement error (as described above),
at the patient and site levels. These correlations are weighted to represent the
sample design in the selection of the patient records for review. All adjusted
analyses were performed using Stata using the GLAM program (Generalized




Most patients in the sample were men (97 percent) and their mean age was
62.4 (SD 5 11.7). For the 2-year time period from October 1, 1997 to Sep-
tember 30, 1999, 25.3 percent of patients were hospitalized at least once, with
a mean of 0.56 hospitalizations per person (SD 5 1.5). Patients had a median
of nine primary care, cardiology, endocrine, or pulmonary outpatient visits
during the 2 years.
Score Comparisons
Table 2 shows that for the unadjusted patient-level scores there is a clear
monotonic relationship for most conditions, so that when quality was rated
more highly by the implicit system it was also rated more highly by the explicit
systems. For example, when implicit review scored preventive care as poor or
very poor, the focused explicit review and global explicit review ratings were
33.2 and 42.6, respectively, but were higher at 72.0 and 73.6, respectively
(po.001), when the implicit rating was good or very good. In a few cases the
monotonic relationship was less apparent (e.g., for COPD in the global explicit
system) or absent (e.g., for hypertension in the focused explicit system).
Tables 3a and 3b show the correlations between the three systems un-
adjusted and adjusted for measurement error in the explicit and implicit
scores. The unadjusted correlations between measurement methods for most
of patient-level scores (e.g., correlation between individual patient’s overall
quality score using the implicit tool compared with using the global tool)
generally fall into the small to medium effect size range (0.1–0.4) (Cohen 1988;
Murphy and Myors 1998). Further, we find that the correlations between the
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adjusted patient-level scores are about 20–50 percent higher than the corre-
lations between the unadjusted patient-level scores. The unadjusted and ad-
justed site-level correlations (e.g., correlation between a site’s overall quality
score using the implicit tool compared with using the global review) are in turn
larger than the correlations at the patient level across all three systems, and
most represent large effect sizes for the three summary scores (overall, all
chronic, and prevention) between the global and implicit systems (Table 3a).
Site-level prevention scores showed particularly high levels of convergence
with correlations in the 0.7–0.9 range (see Table 3a). Any measurement of
quality may contain components that are attributable to how an organization
as a whole functions to provide care and other components that are specific to
a particular patient and his/her interaction with the provider. The relatively
higher correlations at the site-level suggest that there is more agreement











Hypertension, N 5 500 N 5 57 N 5 130 N 5 168 N 5 145
Focused explicit score 89.2 (22.7) 87.5 (23.1) 89.1 (21.4) 89.6 (21.0) .91
Global explicit score 81.7 (35.6) 89.8 (22.6) 92.9 (23.6) 94.3 (18.9) .014
COPD, N 5 167 N 5 13 N 5 44 N 5 71 N 5 39
Focused explicit score 36.7 (39.9) 45.3 (30.8) 58.0 (33.6) 65.4 (36.5) .032
Global explicit score 67.4 (40.9) 63.9 (37.9) 67.9 (36.4) 74.0 (30.5) .72
Diabetes, N 5 258 N 5 34 N 5 80 N 5 68 N 5 76
Focused explicit score 62.7 (26.3) 72.5 (21.5) 74.7 (22.4) 81.3 (16.8) .001
Global explicit score 62.4 (22.1) 65.8 (21.9) 65.6 (22.4) 76.1 (19.0) .003
Prevention, N 5 621 N 5 23 N 5 119 N 5 231 N 5 248
Focused explicit score 33.2 (21.9) 51.4 (23.4) 62.6 (24.9) 72.1 (23.9) o.001
Global explicit score 42.6 (21.8) 53.3 (18.5) 64.9 (19.4) 73.6 (17.3) o.001
All chronic, N 5 620 N 5 77 N 5 158 N 5 199 N 5 186
Focused explicit score 70.3 (26.4) 77.1 (22.7) 78.0 (24.5) 83.2 (21.7) .001
Global explicit score 68.5 (21.1) 70.7 (21.8) 72.3 (24.6) 71.7 (24.0) .67
Overall, N 5 621 N 5 70 N 5 164 N 5 211 N 5 176
Focused explicit score 60.4 (23.1) 67.2 (23.1) 68.5 (22.9) 74.6 (19.2) o.001
Global explicit score 61.9 (18.2) 64.1 (16.4) 68.4 (14.9) 70.0 (15.0) o.001
nFor each condition or clinical area, mean quality explicit system scores were calculated for
patients whose care was rated by implicit reviewers as very poor/poor, borderline poor, adequate,
or good/very good. These patient-level scores are unadjusted for measurement error and mean
scores across implicit rating categories are compared using traditional analysis of variance.
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between the quality measurement systems about the performance on the
components of quality at the organization level than for the patient-specific
components of quality.
For the disease specific scores (hypertension, COPD and diabetes——
Table 3b), the diabetes score correlations seem to be both substantial and
Table 3a: Correlations between Each Set of Measurement Systems for
Overall, All Chronic, and Preventive Care
Level of
Correlation
Correlation between Each Set of Review Systems by Condition Categoryn



















Patient, unadjusted 0.19 0.17 0.37 0.02 0.16 0.16 0.45 0.37 0.47
Patient, adjusted 0.26 0.22 0.51 0.12 0.24 0.22 0.75 0.57 0.68
Site, unadjusted 0.29 0.15 0.67 0.41 0.36 0.17 0.83 0.67 0.73
Site, adjusted 0.48 0.29 0.75 0.59 0.49 0.27 0.89 0.67 0.73
nCorrelation coefficients are derived from the multilevel models that are adjusted for the major
sources of measurement error in the explicit and implicit measurement systems. Patient-
level correlations include effect of patient and site. Correlations in bold are significant at o.05
when a Bonferroni correction for multiple comparisons is applied.
Table 3b: Correlations between Each Set of Measurement Systems for
Hypertension, Diabetes, and Chronic Obstructive Pulmonary Disease (COPD)
Level of
Correlation




















Patient, unadjusted 0.13 0.02 0.09 0.24 0.22 0.38 0.10 0.37 0.12
Patient, adjusted 0.10 0.02 0.01 0.45 0.43 0.56 0.25 0.46 0.12
Site, unadjusted 0.44 0.06 0.04 0.47 0.53 0.49 0.67 0.61 0.60
Site, adjusted —— 0.02 —— 0.61 0.69 0.63 —— 0.55 ——
nCorrelation coefficients are derived from the multilevel models that are adjusted for the major
sources of measurement error in the explicit and implicit measurement systems. Patient-
level correlations include effect of patient and site. Correlations in bold are significant at o.05
when a Bonferroni correction for multiple comparisons is applied. As the global site-level scores
for hypertension and COPD have no variance after adjustment for measurement error and re-
viewer effects, there are no correlations reported with the adjusted global site-level scores.
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similar across the three methods of assessment. The COPD scores followed
the general pattern as the other scores but the correlations were weaker and
less consistent across the systems. Site-level scores obtained using the global
tool for COPD and hypertension had no variance after adjustment for the
uncertainty in the patient-level scores and the reviewer effects, therefore no
correlations are reported for these scores (Table 3b). Further, the hypertension
measures had fairly high amounts of variation for the scores at the patient level
but little evidence of correlation between the scores obtained by the different
measurement methods (small effect sizes and all correlations not significant).
Although the global tool used for this study had 26 indicators for hypertension,
18 of the 26 indicators related only to newly diagnosed cases and 21 of the
indicators applied to fewer than 5 percent of patients identified with hyper-
tension. The median number of indicators applicable per subject was 2 (range
1–18). The focused tool had three indicators that applied to all of the patients
(diet counseling, exercise counseling, and annual blood pressure measure-
ment), and these indicators were met most of the time for all patients. The two
conditions which had the lowest correlations between the methods (hyper-
tension and COPD) were also those for which there were the fewest number of
applicable indicators comprising the score.
CONCLUSION
To our knowledge, this is the largest and most comprehensive study exam-
ining agreement in care quality between such varied performance assessment
methods. The correlations between the instruments, despite the differences in
the measurement systems, support the conclusion that an underlying quality
construct exists for most of the conditions and clinical areas that we examined.
The global explicit system had particularly high convergence with the implicit
system for summary scores and both explicit systems had moderately high
convergence with implicit assessment of quality for all discrete conditions,
except hypertension.
We also demonstrated that the correlations between quality assessment
systems are substantially higher when we adjust for the measurement error
inherent in each of the implicit and explicit systems. Many measurements in
clinical science are imprecise, and we use analytical approaches such as sen-
sitivity, prior probability, and positive predictive value to anchor meaning to
results of such measurements (e.g., abnormal abdominal examinations, pos-
itive cardiac exercise stress tests, and prostate specific antigen values). Quality
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measurements are similarly imprecise, and the imprecision increases for
summary measures. Yet there is a compelling policy need for relatively simple
summary measures of quality in order to implement pay for performance
strategies to improve care. Therefore, methods that adjust for some of the
imprecision in these measurements are essential and also helpful when trying
to understand the relationships between different measures of quality.
Although there was a high degree of convergence across the measure-
ment systems for summary measures of quality, there was also sub-
stantial variation in the amount of agreement seen between measurement
approaches for quality ratings for specific conditions. For example, for pre-
ventive and diabetes care, the agreement across the three instruments was
particularly high (site-level correlations ranging from 0.61 to 0.89). These
content areas are distinguished by having relatively large amounts of pub-
lished evidence and guidelines supporting specific interventions. Thus the two
explicit tools share very similar process indicators and the physician reviewers
have a better and more straightforward evidence-base upon which to form
their judgments.
If availability of evidence contributed to the high correlations for dia-
betes and prevention, then why did we not see a similar trend for hyperten-
sion, which had both low agreement between measures and poor performance
for the explicit scores? The hypertension explicit scores for both the global and
focused methods were notable for having only two to three applicable indi-
cators for most patients and very high pass rates (50 percent of the patients had
a perfect score). This combination of few measurements per person and a
ceiling effect is likely to have reduced the amount of usable information in the
explicit scores to a point where they did not adequately measure the under-
lying construct in this population. Although a similar problem could have also
led to low concordance for COPD measures, it seems more likely that the
much smaller and more nebulous evidence base in COPD care resulted in a
more inherent difficulty achieving convergence between physician assess-
ments and different sets of explicit indicators (Hofer et al. 2004).
This study highlights several important factors about why different ex-
plicit systems and implicit review may agree with one another, even when the
process measures used to assess quality in each system are quite different. For
example, it is possible that explicit systems’ process standards do not capture
the bulk of important decision making, but providers who do well on aspects
of care measured by the explicit tools also do well on aspects of care captured
by implicit review but not by the explicit tools. On the other hand, implicit
reviewers’ judgment as to what defines a quality problem may have been
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influenced (and narrowed) by widespread educational efforts focused around
existing explicit measures. Finally, we must consider that the performance of
explicit systems is dependent on the population. Some process measures may
adequately assess quality of care among patients with mild but not severe
disease, and agreement between different systems could therefore be depen-
dent on the patient population considered.
Our study adds to the existing literature in this area in several important
ways. First, we examined quality using three distinct measures of quality, two
of which are in current use for operations or research purposes. Unlike many
previous studies, each measurement system was developed independently,
and used unique reviewers. Second, we used statistical methods not available
at the time of many of the earlier studies to adjust for the measurement error in
each of the systems, allowing us to produce more accurate scores and cor-
relations. Third, we examined convergence at both the patient and site levels
to inform our findings. This is important because profiling generally occurs at
the site level and these methods may be better suited to evaluating quality for
an entity rather than an individual patient. Finally, we examined agreement
not only for discrete conditions but also for overall quality of care in inpatient
and outpatient settings and across the continuum of care delivery (e.g., pre-
vention, chronic care, overall).
Despite its methodological strengths, our study has some limitations. We
reviewed care among persons who had chronic conditions, and who used care
frequently, in a system that delivers high quality of care ( Jha et al. 2003; Asch
et al. 2004; Kerr et al. 2004). Our conclusions could differ if these tools were
applied to healthier populations or in different health care settings. Second, all
of the measures that comprised the explicit scores were weighted equally. If
implicit reviewers take importance weights into account when rating care (i.e.,
by judging medication intensification for uncontrolled hypertension as more
important than checking an urinalysis), then some of the lack of convergence
may be due to equal weighting in the explicit systems. Failure to weight could
also result in a systematic underestimate of differences in quality if standards
that have a small potential impact on outcomes are more commonly met than
standards that have a high potential impact. Although Ashton et al. (1999)
found little effect of importance weighting on ratings of readiness-for-dis-
charge scores, future research will need to examine whether weighting of
indicators by importance improves the correlations between implicit and ex-
plicit systems for overall quality of care. This study assessed only technical
aspects of care and was limited to factors usually noted in the medical record.
Therefore, we were unable to assess quality of interpersonal care, such as
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effective communication, which could also affect outcomes. While we found
correlations in quality scores at the site level to be moderately high in many
instances, our sampling frame did not allow us to examine correlations at
individual physician levels. Our previous research suggests, however, that
variance in scores may be lower at the physician level than at the site level.
Thus, a larger number of records per physician may be necessary to produce a
reliable score, and consideration of measurement error would be even more
critical (Hofer et al. 1999; Krein et al. 2002).
Our findings also clarify some of the advantages and disadvantages of
these three main approaches to measuring quality. A focused explicit tool pro-
duces scores that are easier to interpret and more easily guide targeted quality
improvement efforts. Summary focused scores are correlated with overall im-
plicit review, and our previous research has shown that organizations that em-
ploy them may experience some benefit in unmeasured but related areas of
quality (Asch et al. 2004). But a focused set of indicators puts a spotlight on only
a few processes of care, opening up the possibility of provider ‘‘gaming’’ and
potential misallocation of resources if other processes are more closely related
to outcomes. If the goal is to distinguish overall quality performance between
facilities or to guide more systemic quality improvement efforts, then the global
explicit and implicit approaches are designed to be more comprehensive and
difficult to game. Our research shows that they are somewhat better correlated
overall with each other than focused systems. The cost of measurement systems
(which we did not directly measure) may tip the balance in deciding which
system to employ. We found that the global system required substantially
longer chart review times than the focused one, and the implicit review system
required more expensive physician reviewers than the other two. How those
findings will translate into measurement costs, especially as more of the needed
information is available electronically, awaits future research.
Our findings also raise a note of caution. In contrast to the systems used
in our study, many commercial profiling systems rely heavily on administra-
tive rather than medical record data, and measures are often developed as
much on the basis of feasibility as on validity and reliability. Previous research
has shown that assessments of quality can be very different (and higher) when
using only measures applicable to administrative data versus using a much
broader set of clinically detailed measures (MacLean et al. 2006). By looking
for quick and inexpensive solutions, the developers of profiling systems that
rely only on currently available administrative data may be producing pro-
files, but we cannot know whether these profiles truly reflect ‘‘quality’’ (versus
utilization, access, or another construct).
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Instead, our findings lend credence to profiling approaches that use
clinically detailed data, such as the approach used in VA, and possibly to
expanding those approaches to cover more conditions in order to capture a
larger slice of ‘‘overall’’ quality (as VA has already begun to do). Clinically
detailed data need not always be retrieved from medical record review but
could be extracted from correctly constructed electronic health records (Kerr
et al. 2003; Kupersmith et al. 2007). Our results suggest that a measurable
construct that represents health care ‘‘quality’’ does indeed exist and can be
discerned with quality assessment systems and appears to be strongest in areas
with a well-developed evidence base and widespread agreement on manage-
ment and treatment. However, before we can reward or punish health care
providers based on their ‘‘quality,’’ we must understand whether the measures
used to assess quality reflect reliable and meaningful estimates of providers’
performance.
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